McKesson Corp. (NYSE:MCK), San Francisco, CA, will acquire RxCrossroads from CVS Health (NYSE:CVS) for $735 million. RxCrossroads provides commercial support, customized pharmacy dispensing and logistics services to pharmaceutical and biotechnology manufacturers.
The acquisition will allow McKesson to grow its end-to-end offerings for manufacturers and add plasma logistics to McKesson’s manufacturer services, complementing the company’s established customer-facing plasma offerings.